Postgraduate Symposium: Flavonoids as modulators of memory and learning: Molecular interactions resulting in behavioural effects

Proceedings of the Nutrition Society

Volumn 71, Issue 2, 2012, Pages 246-262

  Rendeiro, Catarina ^a   Guerreiro, João D T ^b   Williams, Claire M ^a   Spencer, Jeremy P E ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Flavonoids; Hippocampus; Learning; Memory

Indexed keywords

FLAVONOID; TRANSCRIPTION FACTOR; PLANT EXTRACT; PROTEIN;

AMNESIA; BIOAVAILABILITY; BLUEBERRY; BRAIN; COGNITION; CONFERENCE PAPER; DIET SUPPLEMENTATION; GENE EXPRESSION; GINKGO BILOBA; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; MEMORY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; TEA; ANIMAL; BEHAVIOR; DIET; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALIA; GINKGO BILOBA; VACCINIUM;

ANIMALS; BEHAVIOR; COGNITION; DIET; DIETARY SUPPLEMENTS; FLAVONOIDS; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; LEARNING; MEMORY; PLANT EXTRACTS; PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84860872134     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665112000146     Document Type: Conference Paper

References (235)

1. Parrott MD & Greenwood CE (2007) Dietary influences on cognitive function with aging: from high-fat diets to healthful eating. Ann N Y Acad Sci 1114, 389-397.
2. Gomez-Pinilla F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9, 568-578.
3. Greenwood CE & Winocur G (2005) High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging 26, Suppl. 1, 42-45.
4. Molteni R, Barnard RJ, Ying Z et al. (2002) A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 112, 803-814.
5. Ingram DK, Weindruch R, Spangler EL et al. (1987) Dietary restriction benefits learning and motor performance of aged mice. J Gerontol 42, 78-81.
6. Johnson JB, Summer W, Cutler RG et al. (2007) Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 42, 665-674.
7. Letenneur L, Proust-Lima C, Le Gouge A et al. (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165, 1364-1371.
8. Patel AK, Rogers JT & Huang X (2008) FlaVanols, mild cognitive impairment, and Alzheimer?s dementia. Int J Clin Exp Med 1, 181-191.
9. Beking K & Vieira A (2011) Flavonoid intake and disability-adjusted life years due to Alzheimer?s and related dementias: a population-based study involving twentythree developed countries. Public Health Nutr 13, 1403-1409.
10. Nurk E, Refsum H, Drevon CA et al. (2009) Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 139, 120-127.
11. Chan YC, Hosoda K, Tsai CJ et al. (2006) Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice. J Nutr Sci Vitaminol (Tokyo) 52, 266-273.
12. Haque AM, Hashimoto M, Katakura M et al. (2006) Longterm administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 136, 1043-1047.
13. Kaur T, Pathak CM, Pandhi P et al. (2008) Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn 67, 25-30.
14. Kuriyama S, Hozawa A, Ohmori K et al. (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 83, 355-361.
15. Lai HC, Chao WT, Chen YT et al. (2004) Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro. Cancer Lett 213, 181-188.
16. Unno K, Takabayashi F, Yoshida H et al. (2007) Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology 8, 89-95.
17. Oliveira DR, Sanada PF, Saragossa Filho AC et al. (2009) Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence. Brain Res 1269, 68-89.
18. Shif O, Gillette K, Damkaoutis CM et al. (2006) Effects of Ginkgo biloba administered after spatial learning on water maze and radial arm maze performance in young adult rats. Pharmacol Biochem Behav 84, 17-25.
19. Cohen-Salmon C, Venault P, Martin B et al. (1997) Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging. J Physiol Paris 91, 291-300.
20. Itil TM, Eralp E, Ahmed I et al. (1998) The pharmacological effects of Gingko Biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacology 34, 391-396.
21. Fisher ND, Sorond FA & Hollenberg NK (2006) Cocoa flaVanols and brain perfusion. J Cardiovasc Pharmacol 47, Suppl. 2, S210-S214.
22. Francis ST, Head K, Morris PG et al. (2006) The effect of flaVanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47, Suppl. 2, S215-S220.
23. Dinges DF (2006) Cocoa flaVanols, cerebral blood flow, cognition, and health: going forward. J Cardiovasc Pharmacol 47, Suppl. 2, S221-S223.
24. Williams CM, El Mohsen MA, Vauzour D et al. (2008) Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45, 295-305.
25. Casadesus G, Shukitt-Hale B, Stellwagen HM et al. (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309-316.
26. Shukitt-Hale B, Lau FC & Joseph JA (2008) Berry fruit supplementation and the aging brain. J Agric Food Chem 56, 636-641.
27. Joseph JA, Shukitt-Hale B, Denisova NA et al. (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 8114-8121.
28. Krikorian R, Shidler MD, Nash TA et al. (2010) Blueberry supplementation improves memory in older adults. J Agric Food Chem 58, 3996-4000.
29. Mandel S & Youdim MB (2004) Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37, 304-317.
30. Spencer JP (2007) The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2, 257-273.
31. Spencer JP (2008) Flavonoids: modulators of brain function? Br J Nutr 99E, Suppl. 1, ES60-ES77.
32. Shukitt-Hale B, Carey A & Joseph JA (2005) Phytochemicals in foods and beverages: effects on the central nervous system. In Nutritional Neuroscience, pp. 393-403 [C Prasad, editor]. Boca Raton: CRC Press.
33. Beking K & Vieira A (2011) An assessment of dietary flavonoid intake in the UK and Ireland. Int J Food Sci Nutr 62, 17-19.
34. Harnly JM, Doherty RF, Beecher GR et al. (2006) Flavonoid content of U.S. fruits, vegetables, and nuts. J Agric Food Chem 54, 9966-9977.
35. Rice-EVans CA, Miller NJ & Paganga G (1996) Structureantioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20, 933-956.
36. Scalbert A & Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 8S Suppl., 2073S-2085S.
37. Manach C, Scalbert A, Morand C et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747.
38. Scalbert A, Morand C, Manach C et al. (2002) Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 56, 276-282.
39. Spencer JP, Chowrimootoo G, Choudhury R et al. (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224-230.
40. Crozier A, Jaganath IB & Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26, 1001-1043.
41. Spencer JP (2003) Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 133, 3255S-3261S.
42. Crozier A, Del Rio D & Clifford MN (2010) Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31, 446-467.
43. Stalmach A, Mullen W, Steiling H et al. (2010) Absorption, metabolism, and excretion of green tea flaVan-3-ols in humans with an ileostomy. Mol Nutr Food Res 54, 323-334.
44. Renouf M, Guy P, Marmet C et al. (2010) Plasma appearance and correlation between coffee and green tea metabolites in human subjects. Br J Nutr 104, 1635-1640. Flavonoids and brain function 257
45. Del Rio D, Borges G & Crozier A (2010) Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104, Suppl. 3, S67-S90.
46. Kay CD (2006) Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 19, 137-146.
47. Mazza G, Kay CD, Cottrell T et al. (2002) Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 50, 7731-7737.
48. Wu X, Cao G & Prior RL (2002) Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J Nutr 132, 1865-1871.
49. Borges G, Roowi S, Rouanet JM et al. (2007) The bioavailability of raspberry anthocyanins and ellagitannins in rats. Mol Nutr Food Res 51, 714-725.
50. Sakakibara H, Ogawa T, Koyanagi A et al. (2009) Distribution and excretion of bilberry anthocyanins [corrected] in mice. J Agric Food Chem 57, 7681-7686.
51. Kay CD, Kroon PA & Cassidy A (2009) The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products. Mol Nutr Food Res 53, Suppl. 1, S92-S101.
52. Kahle K, Kraus M, Scheppach W et al. (2006) Studies on apple and blueberry fruit constituents: do the polyphenols reach the colon after ingestion? Mol Nutr Food Res 50, 418-423.
53. Spencer JP, Abd El Mohsen MM, Minihane AM et al. (2008) Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99, 12-22.
54. Aura AM, Martin-Lopez P, O'Leary KA et al. (2005) In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 44, 133-142.
55. Tsuda T, Horio F & Osawa T (1999) Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett 449, 179-182.
56. Vitaglione P, Donnarumma G, Napolitano A et al. (2007) Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J Nutr 137, 2043-2048.
57. Williamson G & Clifford MN (2010) Colonic metabolites of berry polyphenols: the missing link to biological activity? Br J Nutr 104, Suppl. 3, S48-S66.
58. Milbury PE & Kalt W (2010) Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. J Agric Food Chem 58, 3950-3956.
59. Youdim KA, Dobbie MS, Kuhnle G et al. (2003) Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85, 180-192.
60. Aasmundstad TA, Morland J & Paulsen RE (1995) Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 275, 435-441.
61. Sperker B, Backman JT & Kroemer HK (1997) The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33, 18-31.
62. Suganuma M, Okabe S, Oniyama M et al. (1998) Wide distribution of [3H]( - )-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771-1776.
63. Abd El Mohsen MM, Kuhnle G, Rechner AR et al. (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33, 1693-1702.
64. Talavera S, Felgines C, Texier O et al. (2005) Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 53, 3902-3908.
65. El Mohsen MA, Marks J, Kuhnle G et al. (2006) Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 95, 51-58.
66. Peng HW, Cheng FC, Huang YT et al. (1998) Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 714, 369-374.
67. Andres-Lacueva C, Shukitt-Hale B, Galli RL et al. (2005) Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8, 111-120.
68. Kalt W, Blumberg JB, McDonald JE et al. (2008) Identification of anthocyanins in the liver, eye, and brain of blueberry- fed pigs. J Agric Food Chem 56, 705-712.
69. Passamonti S, Vrhovsek U, Vanzo A et al. (2005) Fast access of some grape pigments to the brain. J Agric Food Chem 53, 7029-7034.
70. Van Praag H, Lucero MJ, Yeo GW et al. (2007) Plantderived flaVanol ( - )epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 27, 5869-5878.
71. Squire LR & Zola SM (1996) Structure and function of declarative and nondeclarative memory systems. Proc Natl Acad Sci USA 93, 13515-13522.
72. Squire LR & Kandel ER (2009) From Mind to Molecules, 2nd ed. Singapore: Ben Roberts.
73. Cohen NJ & Eichenbaum H (1993) Memory, Amnesia and the Hippocampal System. Cambridge, MA: MIT Press.
74. Lechner HA, Squire LR & Byrne JH (1999) 100 years of consolidation - remembering Muller and Pilzecker. Learn Mem 6, 77-87.
75. Kandel ER & Squire LR (2000) Memory: From Mind to Molecules. New York: W. H. Freeman.
76. Frankland PW & Bontempi B (2005) The organization of recent and remote memories. Nat Rev Neurosci 6, 119-130.
77. Squire LR, Stark CEL & Clark RE (2004) The medial temporal lobe. Ann Rev Neurosci 27, 279-306.
78. Zola-Morgan SM & Squire LR (1990) The primate hippocampal formation: evidence for a time-limited role in memory storage. Science 250, 288-290.
79. King JA, Burgess N, Hartley T et al. (2002) Human hippocampus and viewpoint dependence in spatial memory. Hippocampus 12, 811-820.
80. Burgess N, Maguire EA & O?Keefe J (2002) The human hippocampus and spatial and episodic memory. Neuron 35, 625-641.
81. O?Keefe J (1984) Spatial memory within and without the hippocampal system. In Neurobiology of the Hippocampus, pp. 375-403 [W Seifert, editor]. London: Academic Press.
82. Poucet B & Benhamou S (1997) The neuropsychology of spatial cognition in the rat. Crit Rev Neurobiol 11, 101-120.
83. Shrager Y, Bayley PJ, Bontempi B et al. (2007) Spatial memory and the human hippocampus. Proc Natl Acad Sci USA 104, 2961-2966.
84. Kesner RP & Hopkins RO (2006), Mnemonic functions of the hippocampus: A comparison between animals and humans. Biol Psychol 73, 3-18.
85. Astur RS, Taylor LB, Mamelak AN et al. (2002) Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav Brain Res 132, 77-84.
86. Olton DS & Samuelson RJ (1976) Remembrance of places past - spatial memory in rats. J Exp Psychol Anim Behav Process 2, 97-116.
87. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11, 47-60.
88. Olton DS & Papas BC (1979) Spatial memory and hippocampal function. Neuropsychologia 17, 669-682.
89. Sutherland RJ, Kolb B, Whishaw IQ et al. (1982) Cortical noradrenaline depletion eliminates sparing of spatial-learning after neonatal frontal-cortex damage in the rat. Neurosci Lett 32, 125-130.
90. Bannerman DM, Yee BK, Good MA et al. (1999) Double dissociation of function within the hippocampus: a comparison of dorsal, ventral and complete hippocampal cytotoxic lesions. Behav Neurosci 113, 1170-1188.
91. Barnes CA (1990) Animal models of age-related cognitive decline. In Handbook of Neuropsychology, pp. 169-196 [F Boller and J Grafman, editors]. Amsterdam: Elsevier.
92. Barnes CA (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 93, 74-104.
93. Moffat SD, Zonderman AB & Resnick SM (2001) Age differences in spatial memory in a virtual environment navigation task. Neurobiol Aging 22, 787-796.
94. Gallagher M, Burwell R & Burchinall M (1993) Severity of spatial learning impairments in aging: development of a learning index for performance in the Morris Water Maze. Behav Neurosci 107, 618-636.
95. Wilson IA, Ikonen S, Gallagher M et al. (2005) Ageassociated alterations of hippocampal place cells are subregion specific. J Neurosci 25, 6877-6886.
96. Li Q, Zhao HF, Zhang ZF et al. (2009) Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience 163, 741-749.
97. McGaugh JL (2000) Memory - a century of consolidation. Science 287, 248-251.
98. Lamprecht R & LeDoux J (2004) Structural plasticity and memory. Nat Rev Neurosci 5, 45-54.
99. Muller D, Nikonenko I, Jourdain P et al. (2002) LTP, memory and structural plasticity. Curr Mol Med 2, 605-611.
100. Malenka RC & Nicoll RA (1999) Long-term potentiation - a decade of progress? Science 285, 1870-1874.
101. Bliss TV & Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
102. Lynch G, Rex CS & Gall CM (2007) LTP consolidation: substrates, explanatory power, and functional significance. Neuropharmacology 52, 12-23.
103. Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038.
104. Arnsten AF, Ramos BP, Birnbaum SG et al. (2005) Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11, 121-128.
105. Van der Heide LP, Ramakers GM & Smidt MP (2006) Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 79, 205-221.
106. Kumar V, Zhang MX, Swank MW et al. (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25, 11288-11299.
107. Alkon DL, Sun MK & Nelson TJ (2007) PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer?s disease. Trends Pharmacol Sci 28, 51-60.
108. Bach ME, Hawkins RD, Osman M et al. (1995) Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81, 905-915.
109. Lisman J, Schulman H & Cline H (2002) The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3, 175-190.
110. Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76, 1-10.
111. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14, 311-317.
112. Esteban JA, Shi SH, Wilson C et al. (2003) PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci 6, 136-143.
113. Kim MJ, Dunah AW, Wang YT et al. (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745-760.
114. Malinow R & Malenka RC (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25, 103-126.
115. Zhu JJ, Qin Y, Zhao M et al. (2002) Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110, 443-455.
116. Kelleher RJ III, Govindarajan A, Jung HY et al. (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467-479.
117. Bozon B, Kelly A, Josselyn SA et al. (2003) MAPK, CREB and zif268 are all required for the consolidation of recognition memory. Philos Trans R Soc Lond B Biol Sci 358, 805-814.
118. Davis HP & Squire LR (1984) Protein synthesis and memory: a review. Psychol Bull 96, 518-559.
119. Goelet P, Castellucci VF, Schacher S et al. (1986) The long and the short of long-term memory - a molecular framework. Nature 322, 419-422.
120. Hoeffer CA & Klann E (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33, 67-75.
121. Bekinschtein P, Katche C, Slipczuk LN et al. (2007) mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol Learn Mem 87, 303-307.
122. Hou L & Klann E (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptordependent long-term depression. J Neurosci 24, 6352-6361.
123. Brightwell JJ, Smith CA, Neve RL et al. (2007) Long-term memory for place learning is facilitated by expression of cAMP response element-binding protein in the dorsal hippocampus. Learn Mem 14, 195-199.
124. Sekeres MJ, Neve RL, Frankland PW et al. (2010) Dorsal hippocampal CREB is both necessary and sufficient for spatial memory. Learn Mem 17, 280-283.
125. Barco A, Pittenger C & Kandel ER (2003) CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin Ther Targets 7, 101-114.
126. Impey S, McCorkle SR, Cha-Molstad H et al. (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041-1054.
127. Impey S, Smith DM, Obrietan K et al. (1998) Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1, 595-601. Flavonoids and brain function 259
128. Leil TA, Ossadtchi A, Nichols TE et al. (2003) Genes regulated by learning in the hippocampus. J Neurosci Res 71, 763-768.
129. Finkbeiner S (2000) CREB couples neurotrophin signals to survival messages. Neuron 25, 11-14.
130. Lonze BE & Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623.
131. McAllister AK, Katz LC & Lo DC (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22, 295-318.
132. Poo MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2, 24-32.
133. Cohen-Cory S & Fraser SE (1995) Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 378, 192-196.
134. Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Mem 10, 86-98.
135. Thomas K & Davies A (2005) Neurotrophins: a ticket to ride for BDNF. Curr Biol 15, R262-R264.
136. Bailey CH & Kandel ER (1993) Structural changes accompanying memory storage. Annu Rev Physiol 55, 397-426.
137. Tanaka J, Horiike Y, Matsuzaki M et al. (2008) Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 319, 1683-1687.
138. Nimchinsky EA, Sabatini BL & Svoboda K (2002) Structure and function of dendritic spines. Annu Rev Physiol 64, 313-353.
139. Fischer M, Kaech S, Wagner U et al. (2000) Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat Neurosci 3, 887-894.
140. Messaoudi E, Kanhema T, Soule J et al. (2007) Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J Neurosci 27, 10445-10455.
141. Tzingounis AV & Nicoll RA (2006) Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron 52, 403-407.
142. Bonfanti L (2006) PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol 80, 129-164.
143. Dityatev A, Dityateva G, Sytnyk V et al. (2004) Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal synapses. J Neurosci 24, 9372-9382.
144. Gascon E, Vutskits L & Kiss JZ (2007) Polysialic acidneural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev 56, 101-118.
145. Kiss JZ, Troncoso E, Djebbara Z et al. (2001) The role of neural cell adhesion molecules in plasticity and repair. Brain Res Brain Res Rev 36, 175-184.
146. Li Q, Zhao HF, Zhang ZF et al. (2009) Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade. Neuroscience 159, 1208-1215.
147. Winter JC (1998) The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol Behav 63, 425-433.
148. Rice-EVans C (2001) Flavonoid antioxidants. Curr Med Chem 8, 797-807.
149. Williams RJ, Spencer JP & Rice-EVans C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838-849.
150. Goyarzu P, Malin DH, Lau FC et al. (2004) Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 7, 75-83.
151. Galli RL, Bielinski DF, Szprengiel A et al. (2006) Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. Neurobiol Aging 27, 344-350.
152. Shukitt-Hale B, Lau FC, Carey AN et al. (2008) Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutr Neurosci 11, 172-182.
153. Mandel SA, Amit T, Kalfon L et al. (2008) Targeting multiple neurodegenerative diseases etiologies with multimodal- acting green tea catechins. J Nutr 138, 1578S- 1583S.
154. Mandel SA, Avramovich-Tirosh Y, Reznichenko L et al. (2005) Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, irondependent oxidative stress and PKC signaling pathway. Neurosignals 14, 46-60.
155. Khokhar S & Magnusdottir SG (2002) Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom. J Agric Food Chem 50, 565-570.
156. Higdon JV & Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43, 89-143.
157. Graham HN (1992) Green tea composition, consumption, and polyphenol chemistry. Prev Med 21, 334-350.
158. Kim HK, Kim M, Kim S et al. (2004) Effects of green tea polyphenol on cognitive and acetylcholinesterase activities. Biosci Biotechnol Biochem 68, 1977-1979.
159. Hu G, Bidel S, Jousilahti P et al. (2007) Coffee and tea consumption and the risk of Parkinson?s disease. Mov Disord 22, 2242-2248.
160. Assuncao M, Santos-Marques MJ, Carvalho F et al. (2011) Chronic green tea consumption prevents age-related changes in rat hippocampal formation. Neurobiol Aging 32, 707-717.
161. Nanjo F, Goto K, Seto R et al. (1996) Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl- 2-picrylhydrazyl radical. Free Radic Biol Med 21, 895-902.
162. Grinberg LN, Newmark H, Kitrossky N et al. (1997) Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 54, 973-978.
163. Guo Q, Zhao B, Li M et al. (1996) Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1304, 210-222.
164. Aktas O, Prozorovski T, Smorodchenko A et al. (2004) Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol 173, 5794-5800.
165. Lee S, Suh S & Kim S (2000) Protective effects of the green tea polyphenol ( - )-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287, 191-194.
166. Weinreb O, Amit T & Youdim MB (2007) A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol ( - )-epigallocatechin-3-gallate. Free Radic Biol Med 43, 546-556.
167. Mandel SA, Amit T, Weinreb O et al. (2008) Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther 14, 352-365.
168. Choi YT, Jung CH, Lee SR et al. (2001) The green tea polyphenol ( - )-epigallocatechin gallate attenuates betaamyloid- induced neurotoxicity in cultured hippocampal neurons. Life Sci 70, 603-614.
169. Mandel S, Maor G & Youdim MB (2004) Iron and alphasynuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol ( - )-epigallocatechin-3-gallate. J Mol Neurosci 24, 401-416.
170. Chen C, Yu R, Owuor ED et al. (2000) Activation of antioxidant- response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23, 605-612.
171. Levites Y, Amit T, Youdim MB et al. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol ( - )-epigallocatechin 3- gallate neuroprotective action. J Biol Chem 277, 30574-30580.
172. Koh SH, Kim SH, Kwon H et al. (2003) Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress- induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Brain Res Mol Brain Res 118, 72-81.
173. Levites Y, Amit T, Mandel S et al. (2003) Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol ( - )-epigallocatechin-3-gallate. FASEB J 17, 952-954.
174. Kalfon L, Youdim MB & Mandel SA (2007) Green tea polyphenol ( - )-epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection. J Neurochem 100, 992-1002.
175. Maher P (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neurosci 21, 2929-2938.
176. Dempsey EC, Newton AC, Mochly-Rosen D et al. (2000) Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279, L429-L438.
177. Sun MK, Hongpaisan J & Alkon DL (2009) Postischemic PKC activation rescues retrograde and anterograde long-term memory. Proc Natl Acad Sci USA 106, 14676-14680.
178. Hongpaisan J, Sun MK & Alkon DL (2011) PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer?s disease transgenic mice. J Neurosci 31, 630-643.
179. Sun MK & Alkon DL (2010) Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics. Pharmacol Ther 127, 66-77.
180. Joseph JA, Denisova NA, Arendash G et al. (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153-162.
181. Joseph JA, Shukitt-Hale B, Denisova NA et al. (1998) Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal- transduction and cognitive behavioral deficits. J Neurosci 18, 8047-8055.
182. Shukitt-Hale B, Cheng V & Joseph JA (2009) Effects of blackberries on motor and cognitive function in aged rats. Nutr Neurosci 12, 135-140.
183. Shukitt-Hale B, Cheng V, Bielinski D et al. (2006) Differential brain regional specificity to blueberry and strawberry polyphenols in improved motor and cognitive function in aged rats. Soc Neurosci Abstr 32, 81.15.
184. Borges G, Degeneve A, Mullen W et al. (2010) Identification of flavonoid and phenolic antioxidants in black currants, blueberries, raspberries, red currants, and cranberries. J Agric Food Chem 58, 3901-3909.
185. Shukitt-Hale B, Galli RL, Meterko V et al. (2005) Dietary supplementation with fruit polyphenolics ameliorates agerelated deficits in behavior and neuronal markers of inflammation and oxidative stress. Age 27, 49-57.
186. Ramirez MR, Izquierdo I, do Carmo Bassols Raseira M et al. (2005) Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52, 457-462.
187. Shukitt-Hale B, Carey AN, Jenkins D et al. (2007) Beneficial effects of fruit extracts on neuronal function and behavior in a rodent model of accelerated aging. Neurobiol Aging 28, 1187-1194.
188. Coultrap SJ, Bickford PC & Browning MD (2008) Blueberry- enriched diet ameliorates age-related declines in NMDA receptor-dependent LTP. Age (Dordr) 30, 263-272.
189. Drapeau E, Mayo W, Aurousseau C et al. (2003) Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci USA 100, 14385-14390.
190. Drapeau E, Montaron MF, Aguerre S et al. (2007) Learning- induced survival of new neurons depends on the cognitive status of aged rats. J Neurosci 27, 6037-6044.
191. Kempermann G & Gage FH (2002) Genetic determinants of adult hippocampal neurogenesis correlate with acquisition, but not probe trial performance, in the water maze task. Eur J Neurosci 16, 129-136.
192. Kempermann G, Kuhn HG & Gage FH (1998) Experienceinduced neurogenesis in the senescent dentate gyrus. J Neurosci 18, 3206-3212.
193. Nilsson M, Perfilieva E, Johansson U et al. (1999) Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J Neurobiol 39, 569-578.
194. Shors TJ, Miesegaes G, Beylin A et al. (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410, 372-376.
195. Shors TJ, Townsend DA, Zhao M et al. (2002) Neurogenesis may relate to some but not all types of hippocampaldependent learning. Hippocampus 12, 578-584.
196. Van Praag H (2008) Neurogenesis and exercise: past and future directions. Neuromol Med 10, 128-140.
197. DeFeudis FV & Drieu K (2000) Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1, 25-58.
198. Le Bars PL, Katz MM, Berman N et al. (1997) A placebocontrolled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278, 1327-1332.
199. Hoerr R (2003) Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761. Pharmacopsychiatry 36, Suppl. 1, S56-S61.
200. Kanowski S & Hoerr R (2003) Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36, 297-303.
201. Kanowski S, Herrmann WM, Stephan K et al. (1996) Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multiinfarct dementia. Pharmacopsychiatry 29, 47-56.
202. Chan PC, Xia Q & Fu PP (2007) Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25, 211-244. Flavonoids and brain function 261
203. Le Bars PL, Velasco FM, Ferguson JM et al. (2002) Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer?s disease. Neuropsychobiology 45, 19-26.
204. Oken BS, Storzbach DM & Kaye JA (1998) The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55, 1409-1415.
205. Sierpina VS, Wollschlaeger B & Blumenthal M (2003) Ginkgo biloba. Am Fam Phys 68, 923-926.
206. Winter E (1991) Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol Biochem Behav 38, 109-114.
207. Topic B, Hasenohrl RU, Hacker R et al. (2002) Enhanced conditioned inhibitory avoidance by a combined extract of Zingiber officinale and Ginkgo biloba. Phytother Res 16, 312-315.
208. Hoffman JR, Donato A & Robbins SJ (2004) Ginkgo biloba promotes short-term retention of spatial memory in rats. Pharmacol Biochem Behav 77, 533-539.
209. Walesiuk A, Trofimiuk E & Braszko JJ (2006) Ginkgo biloba normalizes stress- and corticosterone-induced impairment of recall in rats. Pharmacol Res 53, 123-128.
210. Blecharz-Klin K, Piechal A, Joniec I et al. (2009) Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiol Exp (Wars) 69, 217-231.
211. Huang SH, Duke RK, Chebib M et al. (2004) Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. Eur J Pharmacol 494, 131-138.
212. HadjiiVanova CI & Petkov VV (2002) Effect of Ginkgo biloba extract on beta-adrenergic receptors in different rat brain regions. Phytother Res 16, 488-490.
213. Ivic L, Sands TT, Fishkin N et al. (2003) Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA(A) receptors. J Biol Chem 278, 49279-49285.
214. Williams B, Watanabe CM, Schultz PG et al. (2004) Agerelated effects of Ginkgo biloba extract on synaptic plasticity and excitability. Neurobiol Aging 25, 955-962.
215. Tchantchou F, Xu Y, Wu Y et al. (2007) EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer?s disease. FASEB J 21, 2400-2408.
216. Watanabe CM, Wolffram S, Ader P et al. (2001) The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 98, 6577-6580.
217. Wang Y, Wang L, Wu J et al. (2006) The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats. Br J Pharmacol 148, 147-153.
218. Maher P, Akaishi T & Abe K (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA 103, 16568-16573.
219. Jin CH, Shin EJ, Park JB et al. (2009) Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment. J Neurosci Res 87, 3658-3670.
220. Maher P (2009) Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes Nutr 4(4), 297-307.
221. Schroeter H, Bahia P, Spencer JP et al. (2007) ( - )Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem 101, 1596-1606.
222. Spencer JP, Rice-EVans C & Williams RJ (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278, 34783-34793.
223. Weinreb O, Amit T & Youdim MB (2008) The application of proteomics for studying the neurorescue activity of the polyphenol ( - )-epigallocatechin- 3-gallate. Arch Biochem Biophys 476, 152-160.
224. Tully T, Bourtchouladze R, Scott R et al. (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2, 267-277.
225. Radecki DT, Brown LM, Martinez J et al. (2005) BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 15, 246-253.
226. Garzon D, Yu G & Fahnestock M (2002) A new brainderived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer?s disease parietal cortex. J Neurochem 82, 1058-1064.
227. Hwang IK, Yoo KY, Jung BK et al. (2006) Correlations between neuronal loss, decrease of memory, and decrease expression of brain-derived neurotrophic factor in the gerbil hippocampus during normal aging. Exp Neurol 201, 75-83.
228. Laske C, Banschbach S, Stransky E et al. (2010) Exerciseinduced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int J Neuropsychopharmacol 13, 595-602.
229. Laske C, Stransky E, Leyhe T et al. (2006) Stage-dependent BDNF serum concentrations in Alzheimer?s disease. J Neural Transm 113, 1217-1224.
230. Fumagalli F, Racagni G & Riva MA (2006) The expanding role of BDNF: a therapeutic target for Alzheimer?s disease? Pharmacogenomics J 6, 8-15.
231. MarVanova M, Lakso M, Pirhonen J et al. (2001) The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 18, 247-258.
232. Lauterborn JC, Lynch G, Vanderklish P et al. (2000) Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci 20, 8-21.
233. Mackowiak M, O?Neill MJ, Hicks CA et al. (2002) An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology 43, 1-10.
234. Burke SN & Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7, 30-40.
235. Gallagher M (2003) Aging and hippocampal/cortical circuits in rodents. Alzheimer Dis Assoc Disord 17, Suppl. 2, S45-S47.